Navigation Links
Data Suggests Positive Pharmacokinetic Results From Phase I Research of Extended-Release Topiramate
Date:12/6/2010

J. Boulware, Wesley M. Todd

The studies that are the subjects of these posters have been conducted by Upsher-Smith to characterize the pharmacokinetic profile of USL255.  The first poster presented data from numerous internally developed topiramate ER formulations.  The objective of the research presented was to identify a once daily ER formulation with a lower maximum plasma concentration, a higher trough concentration, and an equivalent extent of exposure as compared to IR topiramate.  The PK data from the experimental formulations were compared to IR topiramate, after single doses and/or at simulated steady-state.  Results have aided USL researchers in the formulation selection for USL255.

In another study and second poster presentation, the effect of food on the bioavailability of USL255 was assessed.  In this phase I, randomized, single-dose, crossover study, 36 healthy subjects received three different treatments (200 mg of USL255 under fasting conditions; 200 mg of USL255 with a high fat meal; or 2 doses of 100 mg IR topiramate dosed 12 hours apart).  Based on PK measurements and using standard bioequivalence criteria, the authors determined that the overall extent of absorption of USL255 was not affected by food. However, the presence of food was associated with a delay in the time to maximal plasma concentration of topiramate, a finding that was deemed consistent with the food effect on IR topiramate pharmacokinetics.  

In the third poster, data from the same study compared two 100 mg doses of IR topiramate (administered 12 hours apart) and a single 200 mg dose of USL255 for pharmacokinetic equivalence, using standard bioequivalence criteria.  The authors reported that administration of 200 mg of USL255 in healthy volunteers provided equivalent topiramate exposure as compared with the 100 mg IR topiramate administered twice daily.  USL255 also showed a lower maximum pla
'/>"/>

SOURCE Upsher-Smith
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
2. Study Suggests Soy Protein May Reduce Prostate Cancer Risk
3. Risks Associated With Face Transplants May Be Lower Than Previously Thought, ASPS Journal Review Suggests
4. Recent Data Study Suggests Cortisol Could Help Alleviate Suffering for Those With Chronic Fatigue Syndrome and Fibromyalgia
5. New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly
6. Early Research Suggests Umbilical Cord Blood Cell Therapy May Reduce Progression of Alzheimers Disease
7. MitraClip Device Preliminary Data Suggests Improved Heart Function and Relief from Heart Failure Symptoms in Functional Mitral Regurgitation Patients
8. New Gene Discovery Suggests Which Patients CTIs Brostallicin May Benefit
9. New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery
10. New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR
11. Study Suggests a Possible Way to Offset Chemobrain Memory Loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... -- Sleep Specialists, LLC a medical device company ... Solutions, a leader in digital health and chronic ... and cost reduction program for patients with Obstructive ... chronic medical condition characterized by periods of interrupted ... risk for cardiovascular disease, hypertension, stroke, congestive heart ...
(Date:9/1/2015)... 1, 2015 Taiwan,s ... conference in Taipei on  August ... Vaucarrin™ platform, a targeted drug delivery technology that uses ... This event was part of a joint press conference held ... Inc. (GNT), showcasing GNT,s latest edible gold-based food and ...
(Date:9/1/2015)... 1, 2015 The global ... basis of sectors, products & services and application. And ... with the increasing demand of advanced drugs for ... propel the growth for bioinformatics market. The implementation ... is known as bioinformatics. Decreasing cost of DNA ...
Breaking Medicine Technology:Sleep Specialists, LLC and HGE Health Care Solutions Announce Comprehensive Sleep Program 2GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 2GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 3GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 4GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 5Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 2Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 3Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 4
... 2012 MAP Pharmaceuticals, Inc. (Nasdaq: MAPP ) today ... The net loss for the first quarter ended ... of $16.0 million during the same period in 2011. The net ... one-time expense of $2.8 million for the purchase of a data ...
... 3, 2012  Gen-Probe Incorporated (NASDAQ: GPRO ) announced ... upcoming investor conferences previously announced on April 26, 2012, and ... conferences: , Deutsche Bank 37th Annual Health Care ... Time;  , Baird,s 2012 Growth Stock Conference in Chicago ...
Cached Medicine Technology:MAP Pharmaceuticals Reports First Quarter of 2012 Financial Results 2MAP Pharmaceuticals Reports First Quarter of 2012 Financial Results 3MAP Pharmaceuticals Reports First Quarter of 2012 Financial Results 4MAP Pharmaceuticals Reports First Quarter of 2012 Financial Results 5Gen-Probe Withdraws from Previously Announced Investor Presentations 2
(Date:9/1/2015)... ... 01, 2015 , ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) ... the LATINA Style 50 Report that recognizes companies that provide the best career opportunities ... BCBSNJ climbs from number 24 to 21 of the 50 Best Companies for Latinas. ...
(Date:9/1/2015)... ... September 01, 2015 , ... Consumers overwhelmingly ... Society for Dermatologic Surgery, according to a new survey that also offers insight ... Cosmetic Dermatologic Procedures – which reflects views on cosmetic medical treatments and ratings ...
(Date:9/1/2015)... , ... September 01, 2015 , ... ... that creates negative pressure inside a wound to remove exudates, fluid, and infectious ... devices (comprising portable devices, stand-alone devices, disposable devices, and canisters, etc.) is projected ...
(Date:9/1/2015)... NJ (PRWEB) , ... September 01, 2015 , ... ... with Cleveland Clinic, ranked a top-five hospital by U.S. News & World Report, ... for cancer patients. , Editorial and marketing groups within OncLive, which provides ...
(Date:9/1/2015)... ... 01, 2015 , ... PetPace, the provider of an innovative ... activity, today announced its integration with leading veterinary Practice Management Software vendor Cornerstone. ... Practice Management Software packages in the US. Practice Management Software helps veterinarians manage ...
Breaking Medicine News(10 mins):Health News:Horizon Blue Cross Blue Shield of New Jersey Named One of the 50 Best Companies for Latinas by Latina Style Magazine 2Health News:Horizon Blue Cross Blue Shield of New Jersey Named One of the 50 Best Companies for Latinas by Latina Style Magazine 3Health News:Survey: Consumers Prefer ASDS Members 2Health News:Survey: Consumers Prefer ASDS Members 3Health News:World Negative Pressure Wound Therapy Market Assessed by GlobalData in In-demand Report Published at MarketPublishers.com 2Health News:World Negative Pressure Wound Therapy Market Assessed by GlobalData in In-demand Report Published at MarketPublishers.com 3Health News:OncLive® and Cleveland Clinic Team up to Provide News, Information About Cancer Research and Patient Care 2Health News:OncLive® and Cleveland Clinic Team up to Provide News, Information About Cancer Research and Patient Care 3Health News:Petpace-Cornerstone Integration Lowers Overhead, Raises Data Visibility for Veterinary Practices 2
... , , , , ... Jan. 28 /PRNewswire-Asia-FirstCall/ -- Biostar,Pharmaceuticals, Inc. (OTC ... manufacturer and supplier of pharmaceutical,products and medical nutrients addressing ... January 22, 2010 , its Board of Directors ...
... ... it has been selected by Central Garden & Pet Company (NASDAQ:CENT) as its sole ... ... the leading MSDS and chemical data management company, announced today that it has been ...
... ... data is much easier these days for Abba House – a 12-month ... Since partnering with Global Vision Technologies (GVT) and implementing FAMCare® – ... their data faster – giving them a clearer picture of how their ...
... ... against a disabled person. , ... San Jose, CA (PRWEB) January 28, 2010 -- Covidien, formerly Tyco Healthcare, with revenue in ... discriminated against and refused to hire a potential employee based solely on the fact that ...
... Vibrant ... arthritis pain relief blog. Painreliefcream.info provides news, updates and information on arthritis and joint ... ... the sponsorship of http://www.painreliefcream.info/ a specialty arthritis pain relief blog. Painreliefcream.info provides ...
... ... international events for Valentine,s weekend in Las Vegas: The USA ... the Power Pilates "Power Higher" Conference will host Pilates professionals worldwide. ... teams, Pilates professionals and thousands of spectators from around the world ...
Cached Medicine News:Health News:Biostar Pharmaceuticals, Inc. Announces Change of Auditor 2Health News:Biostar Pharmaceuticals, Inc. Announces Change of Auditor 3Health News:Central Garden & Pet Selects SiteHawk as Its MSDS Management Provider 2Health News:Abba House Partners With Global Vision Technologies - First Adult Residential Case Management System of Its Kind 2Health News:Abba House Partners With Global Vision Technologies - First Adult Residential Case Management System of Its Kind 3Health News:Abba House Partners With Global Vision Technologies - First Adult Residential Case Management System of Its Kind 4Health News:Covidien Sued By Samuelson, Wilson and Roe for Disability Discrimination 2Health News:Covidien Sued By Samuelson, Wilson and Roe for Disability Discrimination 3Health News:Vibrant Health Co Sponsors Specialty Arthritis Pain Relief Blog, painreliefcream.info 2Health News:Rugby & Pilates Have a Date for Valentine's Weekend in Vegas 2Health News:Rugby & Pilates Have a Date for Valentine's Weekend in Vegas 3Health News:Rugby & Pilates Have a Date for Valentine's Weekend in Vegas 4Health News:Rugby & Pilates Have a Date for Valentine's Weekend in Vegas 5
... volume Finnpipette Techpette combines form ... performance pipette. Advanced pipetting technology, ... ensures quality, safety, comfort and ... volume range is an important ...
Inquire...
... ergonomic design reduces hand fatigue, prevents injury. Dry seal technology. No cleaning, ... 100-1000 Inaccuracy (%) ... Imprecision(%) ... 10 Dimensions: ...
... Finnpipette Focus from Thermo Labsystems was designed ... Advanced features such as the new ... adjustment on microvolumes help to define this ... pipettes. The new interchangeable handle plate offers ...
Medicine Products: